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Introduction 
 Tuberculosis (TB), caused by 
Mycobacterium tuberculosis is a leading killer 
that has plagued mankind for centuries. The 
disease is estimated to infect 8 million and kill 
2 - 3 million people each year (Rouse et al., 
1995; Manca et al., 1997). A frequently used 
drug to treat TB is isonicotinic acid hydrazide 
(INH/ isoniazid) but unfortunately, INH-
resistant M. tuberculosis organisms are 
becoming quite common now. In a recent 
survey of 35 countries, 12.6 % of M. 
tuberculosis isolates were found to be 
resistant to at least one drug, including INH 
(Ahmad & Mustafa, 2001). 
Studies strongly implicated an enzymatic 
step(s) in the elongation of fatty acids, and the 
biosynthesis of the very long fatty acyl chains 
of mycolic acids as the site of action of INH 
(Winder & Collins, 1970; Davidson & 
Takayama, 1979; Quemard, 1991). The inhA 
gene product, InhA, was proposed involved in 
the synthesis of fatty acids, presumably the 
unique mycolic acid components of the outer 
mycobacterial cell and has been suggested to 
be the site of action of INH (Banerjee et al., 
1994; Wang et al., 1998; Vilchèze et al., 
2000).  
The deletions and missense mutations 
within the katG gene are common in INH-
resistant clinical isolates of M. tuberculosis 
added evidences in support of the role of 
katG-encoded catalase-peroxidase (Stoekle et 
al., 1993; Heym et al., 1995). These strongly 
suggest that INH is a prodrug which requires 
the katG gene product, KatG, to be activated 
as an antitubercular (Zhang et al., 1996; 
Manca et al., 1999; Lei et al., 2000). Once 
metabolized by KatG, the activated INH 
metabolite reacts with nicotinamide adenine 
dinucleotide (NAD+) to form isonicotinic 
acyl-NADH (INADH), which is the inhibitor 
of InhA. 
Zhang et al. (1992) confirmed that the 
resistance towards INH is related to the loss of 
KatG catalase activity. Besides katG 
mutations, mutations in several genes such as 
inhA, ahpC, kasA and ndh (Vilchèze et al., 
2000; Torres et al., 2000) and genomic 
regions of M. tuberculosis are involved in the 
occurrence of resistance to INH (Piatek et al., 
2000; Slayden & Barry, 2000). Banerjee et al. 
(1994) have shown that low-level resistance to 
INH in some mycobacterial strains is 
associated with mutations in the inhA gene. 
Mutations occurring in both katG and inhA 
genes may account up to 80% of all organisms 
resistant to this critical antituberculosis agent 
(Morris et al., 1995; Musser et al., 1996) with 
the mutations in katG account for the majority 
of INH-resistant clinical isolates (Cynamon et 
al., 1999; Torres et al., 2000). 
Reports (Rouse et al., 1995; Miesel et al., 
1998; Rozwarski et al., 1998) have shown that 
some INH resistant tuberculosis isolates had a 
single base change, from thymine to guanine 
at nucleotide 280 resulting in a serine to 
alanine replacement in codon 94 (S94A) in 
inhA gene. Basso et al. (1998) have proposed 
that INH-resistance in this S94A mutation 
strain is related to the reduced NADH binding 
affinity for enoyl reductase. This is supported 
by an X-ray crystallographic study which 
showed that there is a reduction in the 
hydrogen bonding network between NADH 
and InhA enzyme.  
Molecular modeling techniques have been 
used to understand the mechanism of 
interaction between a protein and a ligand, 
substrate or inhibitor, at the atomic level. 
Molecular docking is one of the most widely 
used methods to predict the binding 
mechanism of ligand binding. While 
molecular dynamics simulations is able to 
give insights into the natural dynamics on 
different timescales of biomolecules. Here, we 
report a study utilizing molecular docking and 
molecular dynamics simulations in our effort 
to understand the interactions of INH and also 
to address the mechanism of resistance by M. 
tuberculosis towards it at the atomic level.  
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 Materials and methods 
 
Molecular docking 
The atomic coordinates of INH  and INH 
derivatives (Figure 1) were generated using 
HYPERCHEM program (Hypercube, Inc.). 
The ligands initial structures of INADH and 
NADH were taken from Brookhaven Protein 
Data Bank (PDB) coordinates (the ligands of 
1ZID and 1ENZ, respectively). The atomic 
coordinates of the wild type, WT and the 
mutant type, MT InhA enzymes were taken 
from the PDB as well. (The PDB ids for WT 
and MT InhA enzymes are 1ZID and 1ENZ, 
respectively.) Polar hydrogen atoms were 
added with the protonate program package 
and charges from the AMBER force field 
were assigned to each atom using the 
kollua.amber utility of AutoDock version 3.0. 
The docking experiments were carried out 
employing the docking program 
AutoDock3.0. (Morris et al., 1998). The grid 
maps for each atom type in ligands were 
calculated using AutoGrid3.0 with 90×90×90 
points and a grid point spacing of 0.375Å. The 
Lamarckian genetic algorithm begins by 
creating a population of 50 individuals with 
the maximum number of energy evaluations 
set to 1500000 and maximum number of 
generations to 27000. The translational step 
size was 0.2 Å, and the orientational and 
torsional step sizes were 5.0° in each case. 
The probability that a particular “gene” would 
undergo crossover and mutation was 0.80 and 
0.02, respectively. An elitism value of 1 was 
used which was the number of top individuals 
that will automatically survive into the next 
generation. The probability of performing 
pseudo-Solis and Wets local search on an 
individual was 0.06. 300 iterations were 
executed per local search with the termination 
value of 0.01. The maximum number of 
consecutive successes or failures before 
doubling or reducing the local search step size 
was 4 in both cases. A maximum of 100 
docking runs were carried out for each ligand. 
After multiple docking runs, cluster analysis 
was carried out. In each docking, results 
differing by less than 1.5 Å root mean square 
deviations were grouped into clusters.  
Molecular dynamics simulations 
All MD simulations presented in this 
work were performed by using the Amber 
version 8.0 simulation package (Case et al., 
2004), the Cornell et al. (1995) all atom force 
field and the parm99.dat parameter set 
(Cheatham et al., 1999) with the TIP3P water 
model (Jorgensen et al., 1983) and primary 
cut off distance for non-bonded interactions 
were set to 12.0 Å.  
The starting structure of INADH-WT InhA 
complex was taken from the PDB (PDB ID: 
1ZID). While for INADH-S94A MT InhA, 
the S94A structure was taken from PDB (PDB 
ID: 1ENZ) and the INADH structure was 
taken from lowest docked energy in the most 
populated cluster since the INADH-S94A 
complex was not posted in PDB. Na+ ion(s) 
were added to the systems to ensure explicit 
net neutralizing counterions. All the systems 
were immersed in a 10 Å length truncated 
octahedron box. The crystallographic water 
molecules in the both WT and MT complex 
were retained to preserve the core water 
molecules involved in the specific hydrogen 
bonding with the protein residues. The 
INADH, INADH-WT and INADH-S94A 
system have total of 5655, 27559 and 27957 
atoms, respectively. 
The system was subsequently energy 
minimized with steepest descend method for 
1000 steps, followed by conjugate gradient for 
another 1000 steps. For MD simulations, a 
total 500,000 steps was run with the time step 
of 2 fs which correspond to 1 ns of MD were 
performed. All simulation started at 0 K 
temperature, slowly warmed up and 
maintained at 300 K using the Berendsen 
coupling algorithm (Berendsen et al., 1984) 
with 0.5 pico-second (ps) coupling time. 
Computational time and space were saved 
where all bonds involving hydrogen atom 
were constrained and were omitted using 
SHAKE algorithm (Ryckaert et al., 1977). 
The trajectory for MD simulation was 
collected and analysed for the last 800 ps of 
the simulation. Structural fluctuation was 
analysed using ptraj module in AMBER8.  
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FIGURE 1     The chemical structure of INH derivatives (INH5 to INH16, INH18 and INH20). 
 
Results 
Figure 2 shows the superimposition of the 
WT InhA on the MT InhA enzyme 
crystallographic structure with the root mean 
squared deviation, rmsd (of the backbone) of 
0.61Å indicating that there is a high structural 
similarity with minor differences between the 
WT and the MT enzymes as a result of 
mutation of serine 94 to alanine. The deviation 
in structures was found mainly within the 
region near the mutant site. Upon docking of 
INA-NADH to the WT InhA, it was found 
that the ligand docked in almost the same 
binding mode within an rmsd of 1.054 Å 
(Figure 3). Docking of NADH on the MT 
InhA showed an rmsd of 0.982 Å for the 
lowest free energy of binding structure with 
the crystal structure (Figure 4). As discussed 
by Jones and co-workers (1995) and Kramer 
and co-workers (1999) a value of rmsd less 
than 2 Å is considered acceptable for docking 
solutions.  
 The rmsd between the INADH docked 
onto the mutant enzyme with the reference 
structure (crystallographic structures in WT 
InhA; PDB ID: 1ZID) is 2.519 Å (Figure 3). 
This indicates that molecular docking is able 
to distinguish the interaction in the WT and 
MT InhA. INH was also found to dock within 
the active site of the WT InhA, forming two 
hydrogen bonds with the enzyme. In contrast, 
INADH forms nine hydrogen bonds while 
NADH forms eight hydrogen bonds with the 
enzyme. In the MT enzyme, it was found that 
while the hydrogen bonds formed with INH 
remains unchanged, there were marked 
reductions of hydrogen bonds formed in 
NADH and more so in INADH. A summary 
of hydrogen bonding interactions of the 
ligands, INA-NADH, NADH and INH is 
represented in Table 1 (also Figure 5 and 6). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2      The line model of superimposed of WT 
(blue line; PDB ID: 1ZID) and S94A MT InhA (red 
line; PDB ID: 1ZID). The WT serine94 is in green 
line while the MT alanine94 is in yellow line. The 
backbone root mean square deviation between the 
two structures is 0.61 Å. 
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FIGURE 3      Docked conformation of isoniazid 
(INH; yellow sticks presentation), NADH (pink 
sticks), isonicotinic acyl-NADH (INADH; blue 
sticks) and the x-ray crystallographic structure of 
INA-NADH (PDB ID: 1ZID; green stick) and NADH 
(PDB ID: 1ENZ; red stick) in the active site (white 
surface) of WT InhA (grey surface; PDB ID: 1ZID). 
 
FIGURE 4      Docked conformation of isoniazid 
(INH; red sticks presentation), NADH (blue sticks), 
isonicotinic acyl-NADH (INADH; yellow sticks) and 
the x-ray crystallography structure of NADH (PDB 
ID: 1ENZ; green sticks) in the active site (white 
surface) of MT InhA (grey surface; PDB ID: 1ENZ). 
 
 
FIGURE 5      Docked conformation of isonicotinic 
acyl-NADH (INA-NADH; ball and stick) in the active 
site (grey line) of S94A (grey stick represented 
alanine94) MT InhA (PDB ID: 1ENZ; ribbon). Green 
doted line shows the hydrogen bonds between INADH 
and InhA. Residues within 4Å of INADH are shown. 
  
FIGURE 6      Docked conformation of isonicotinic 
acyl-NADH (INADH; ball and stick) in the active 
site (grey line; grey stick represented serine94) of 
WT InhA (PDB ID: 1ZID; ribbon presentation). 
Green doted line shows the hydrogen bonds between 
INADH and InhA. Residues within 4Å of INADH 
are shown. 
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 TABLE 1  Summary of hydrogen bonds, hydrophobic contacts, van der Waals, electrostatic and π-π 
interactions between isoniazid (INH), NADH and isonicotinic acyl-NADH (INADH) with WT (PDB ID: 
1ZID) and S94A MT (PDB ID: 1ENZ) InhA. 
 
 Number of interaction Docking calculation 
 
 
System 
 
H- 
bond 
 
Hydro-
phobic 
 
van der 
Waals 
 
Electro- 
static 
 
 
π-π 
Inhibition 
constant 
(g/ml) 
Free energy 
(∆G) 
(kcal/mol) 
 
RMSD 
(Å) 
         
WT-INH 2 7 12 12 1 5.67 x 10-5 -5.79 NA 
MT-INH 2 5 9 9 0 1.22 x 10-4 -5.34 NA 
WT-NADH 8 15 26 26 2 8.83 x 10-10 -12.35 0.94 
MT-NADH 6 17 28 28 2 1.95 x 10-9 -11.88 0.98 
WT-INADH 9 16 29 29 4 3.79 x 10-13 -16.95 1.05 
MT-INADH 5 15 27 27 3 4.39 x 10-11 -14.39 2.52 
         
 
Table 1 also summarizes the different types of 
protein-ligand interactions between INH, 
NADH and INADH and the WT and mutant 
InhA. The residues within 4.2 Å from the 
ligand are taken into account for the van der 
Waals interactions. The same distance is also 
used for hydrophobic residues which from 
hydrophobic contact with the ligand following 
suggestion by Torshin (1999) that the 
hydrophobic interaction occurs when the 
distance between two atoms is less than or 
equal to the sum of their van der Waals radii. 
INH forms 7 hydrophobic contacts, 12 van der 
Waals interactions and 12 electrostatics 
contacts, and NADH has 15 hydrophobic 
contacts, 26 van der Waals interactions and 26 
electrostatic contacts while INADH has same 
number of hydrophobic contacts with NADH, 
29 van der Waals interactions and 29 
electrostatic contacts with WT InhA. The 
pyridine ring of INH with Phe41 in WT InhA 
also contributed to the π-π interaction. 
Adenine ring of NADH made π-π interaction 
with Phe41 and Phe97 in contrast, this ring of 
INADH only make π-π interaction with Phe41 
while its pyridine ring was making this type of 
interaction with Phe149, Tyr158 and Trp222. 
In S94A MT InhA, INH made 5 hydrophobic 
contacts but less van der Waals and 
electrostatic contacts are observed. The same 
observation is found for INA-NADH where it 
forms the same number of hydrophobic 
contacts, but the number of van der Waals 
interaction and electrostatic contacts were 
both reduced to 27. INH did not contribute to 
the π-π interaction, however in INADH, the 
pyridine ring was no more making π-π 
interaction with Trp222. On the other hand, 
NADH made slightly more hydrophobic 
contacts, van der Waals interactions and 
electrostatic contacts in the MT InhA than 
with the WT InhA but forms the same number 
of π-π interaction in both the wild and the MT 
InhA. 
 It is interesting to note that residues Gly14, 
Ile15, Ile16, Phe41, Leu53, Asp64, Val65 and 
Ile95 of the WT InhA interact with INH and 
are within the NADH binding site of the 
activated complex (INADH). This clearly 
shows that INH is actually bound to binding 
region of the NADH portion of INADH as 
clearly shown in Figure 3 and 4 which also 
suggests that this binding region is more 
important as the ligand binding site. 
Table 1 shows the calculated interaction 
energies for the lowest free energy binding 
conformations of INADH, NADH and INH. 
The estimated free energy of binding of 
INADH to the WT and MT InhA is -16.95 
and -14.39 kcal/mol, respectively. In the case 
of NADH, a slight increased in the free energy 
of binding was observed (∆G: WT:  -12.35 
kcal/mol; MT: -11.88 kcal/mol). Even though 
INH also binds at the same binding site, it did 
so with much increased binding free energy 
(∆G: WT:  -5.79 kcal/mol; MT: -5.34 
kcal/mol). 
From MD simulation of WT-INADH and 
MT-INADH, free energy of binding 
calculations showed the same trend as in 
docking calculation. (∆G: WT-INADH:  -
45.18 kcal/mol; MT-INADH: -43.17 
kcal/mol). Average structure from MD 
simulation of INADH-WT and INADH-MT 
(Figure 7) show that similar conformation as 
in docking where the polar phosphate group of 
INADH shift away from the Ala94 in MT 
InhA.  
The binding conformation of INH 
derivatives in WT and MT InhA were shown 
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 in Figure 8. Results show that all the INH 
derivatives were at the same binding site of 
INADH in both WT and MT InhA. The INH 
derivatives filled up the active site of WT and 
MT InhA from the adenine end to the pyridine 
end of INADH molecule, when going from 
INH5 (34 atoms) as the smallest size of INH 
derivative, to INH20 as the largest INH 
derivative (79 atoms). It is found that the INH 
derivatives was gradually fill up the active site 
of WT and MT when the aliphatic chain of the 
INH derivative getting longer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 shows the estimated free energy of 
binding (∆G) in WT and MT InhA. It was 
observed that the free energy in both WT and 
MT InhA getting lower when the aliphatic 
side chain of the INH derivative getting 
longer. In WT InhA, INH15, INH16 and 
INH20 were the ligand with the lowest free 
energy among the INH derivatives. While 
INH11, INH15 and INH16 were having the 
lowest free energy in the MT InhA. INH20 
docked into WT InhA is the only INH 
derivatives which has the free energy lower 
than -10 kcal/mol. INH20 has the inhibition 
constant (Ki) value less then 10-8 while INH9, 
INH10, INH12, INH13, INH14, INH15 and 
INH16 were the INH derivatives which have 
the Ki value less then 10-7 in WT InhA. In MT 
InhA, INH11 and INH16 have the Ki value 
less then 10-8, while INH7, INH8, INH9, 
INH10, INH12, INH13, INH14, INH15 and 
INH20 are the INH derivatives with Ki value 
less then 10-7 (Table 3.2). From the 
experimental data (Ibrahim, 1996; Mohamad 
et al., 2004), it was found that INH14, INH16 
and INH18 have the lowest minimum 
 
(a) 
 
(b) 
FIGURE 8     Docked conformation of a) INH5-
INH11 and b) INH12-16, INH18 and INH20 in the 
WT InhA compare with the crystal structure of 
INADH. surface) of WT InhA (grey surface; PDB 
ID: 1ZID). 
 
(a) 
 
(b) 
FIGURE 7    Average structure from MD simulation 
of a) INADH-WT InhA and b) INADH-MT InhA. 
INADH in CPK presentation while InhA in line 
ribbon presentation. 
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 inhibitory concentrations (MIC) of 0.010 
µg/ml in H37Rv WT M. tuberculosis.  MIC 
value is going lower from ligand with a short 
aliphatic side chain (INH5) to ligand with 
longer aliphatic side chain (INH18). Figure 9 
shows that the docking results were consistent 
with the experimental MIC value where the Ki 
value is getting lower from INH derivative 
with a short aliphatic side chain (INH5) to 
INH derivative with longer aliphatic side 
chain (INH20). 
 
TABLE 2  Calculated energy of INH derivatives 
docked into WT and MT InhA. 
 
Ligand - 
InhA 
System 
Calculated 
Free Energy 
(∆G, kcal/mol) 
Inhibition 
constant, Ki 
(g/ml) 
INH5 - WT -6.97 7.77 x 10-6 
INH5 - MT -7.65 2.46 x 10-6 
INH6 - WT -7.30 4.47 x 10-6 
INH6 - MT -7.83 1.83 x 10-6 
INH7 - WT -7.68 2.35 x 10-6 
INH7 - MT -8.19 9.90 x 10-7 
INH8 - WT -7.84 1.78 x 10-6 
INH8 - MT -8.51 5.57 x 10-7 
INH9 - WT -8.25 9.03 x 10-7 
INH9 - MT -8.45 6.44 x 10-7 
INH10 - WT -8.45 6.40 x 10-7 
INH10 - MT -8.71 4.15 x 10-7 
INH11 - WT -8.07 1.22 x 10-6 
INH11 - MT -9.57 9.73 x 10-8 
INH12 - WT -9.24 1.60 x 10-7 
INH12 - MT -8.56 5.35 x 10-7 
INH13 - WT -8.39 7.11 x 10-7 
INH13 - MT -9.14 1.98 x 10-7 
INH14 - WT -8.76 3.82 x 10-7 
INH14 - MT -9.42 1.24 x 10-7 
INH15 - WT -9.25 1.66 x 10-7 
INH15 - MT -9.47 1.15 x 10-7 
INH16 - WT -9.47 1.14 x 10-7 
INH16 - MT -9.59 9.36 x 10-8 
INH18 - WT -8.44 6.52 x 10-7 
INH18 - MT -9.54 1.01 x 10-7 
INH20 - WT -10.28 2.92 x 10-8 
INH20 - MT -9.40 1.28 x 10-7 
 
Discussions 
In this study, we attempted to address the 
resistance mechanism towards INH. Based on 
the finding that INH must be activated to form 
INA-NADH by KatG, we hypothesize that in 
katG mutant or deleted M. tuberculosis, INH 
would not be activated to form the INA-
NADH complex. Thus, the interactions of the 
drug and its active metabolite on InhA can be 
used to explain the resistance phenomena in 
the organism.  
From the present study, there is a clear 
deviation in the conformation of INADH in 
S94A MT InhA in compared to its crystal 
structure conformation in the WT enzyme. 
From the analysis of the docked 
conformations, all the hydrogen bonds made 
are near to the NADH part of the INA-NADH 
and none were at the isonicotinic acyl 
(pyridine ring) region of this ligand. The 
number of hydrogen bonds made by INA-
NADH docked to the WT InhA was 9 
compared to 5 by INADH in MT InhA. This 
probably has weakened the binding affinity of 
INADH towards mutant InhA. Similar 
observation was made by Chen et al. (2001) 
upon investigation on the binding of NADH to 
the WT and MT InhA. It is interesting to note 
that their calculation showed a marked 
difference between the experiment and the 
predicted ∆E. They have attributed this to the 
fact that the optimization/scoring procedure 
might not properly account factors such as 
hydrophobic factors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Close inspection of the docked complexes 
showed that the adenine ring at the NADH 
part of INA-NADH contributes 75% of the 
aromatic ring-stacking interaction (π-π 
interaction). These observations suggest that 
NADH make an important role for a good 
binding affinity. The docked conformation 
also suggests that NADH is a crucial molecule 
that is needed to bind covalently with INH 
metabolite before it can act as an 
antitubercular. These same observations have 
also been found by Dessen et al. (1995) where 
they suggested that the mechanism of INH 
may be related to specific interactions 
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FIGURE 9      Calculated inhibition constant (Ki) 
value of INH derivatives docked into WT InhA 
compare with experimental minimum inhibitory 
concentration (MIC) value of INH derivatives in M. 
tuberculosis H37Rv. 
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 between InhA enzyme and cofactor within the 
NADH binding site. The phenomenon of the 
pyridine ring of INADH was sandwiched 
between Ala191 and Phe149 while adenine 
ring of INADH was found sandwiched 
between Val65 and Phe41 has agreed with 
Denessiouk and Johnson (2000) where these 
researchers discovered that aromatic ring is 
often seen sandwiched between hydrophobic 
residue on one face on the ring and aromatic 
residue on the opposite face of the ring to 
strengthen the π-π interaction in INADH. INH 
is a relatively small molecule (17 atoms) 
compared with INA-NADH (82 atoms). 
INADH have more hydrophobic contacts, van 
der Waals, electrostatic as well as the π-π 
interactions with InhA in comparison to INH 
thus explains the lower interaction energies 
INADH has with InhA than that of INH with 
the enzyme. 
It has been observed by X-ray 
crystallographic studies that S94A mutant 
displays a reduced hydrogen bond pattern 
between NADH and the enzyme. This is 
consistent with our observation from the 
docking simulations of WT and MT InhA 
enzyme. The location of S94A mutation is 
within the NADH binding region (Figure 5). 
The serine to alanine mutation at codon 94 in 
mutant InhA introduces differences in the side 
chain with the substitution of hydroxyl group 
in serine to hydrogen in alanine. This has 
caused the amino acid hydrophobicity 
property to shift from a polar to non-polar 
amino acid resulting in the two polar 
phosphate groups in INADH to drift away 
from the non-polar Alanine 94 causing the 
INADH conformation to deviate from the 
crystal structure with the WT complex. 
Therefore, it is proposed that the substitution 
of serine residue by alanine has interferes 
directly the INADH binding. Further 
investigation reveals that in the MT enzyme, 
Asp64 and Val65 are now more than 4Å from 
INADH and not to be seen within the INADH 
binding site. Ile21 and Gly94 are also too far 
away, more than 3Å to be hydrogen bonded 
with INA-NADH. Furthermore, the hydrogen 
bond length made by INADH was slightly 
longer in MT InhA than that in the WT InhA 
implicating weaker interactions of the ligand 
in the MT InhA. 
It is also worth discussing here that the 
S94A mutation in InhA even though resulted 
in deviation docked conformation from the 
WT enzyme, the calculated ∆G due to the 
mutation is not as low as should the activated 
complex could not be formed compare ∆G for 
INH (unactivated by katG) and INADH 
(activated complex)]. This implies factors 
other than the mutation on the InhA are more 
important to account for the resistance of the 
mycobacterium towards INH. One such factor 
could be that InhA is an NADH-dependent 
enoyl acyl carrier protein reductase. As the co-
factor, the presence of NADH is extremely 
important for the activity of the enzyme and 
this can be clearly demonstrated from our 
docking studies where high affinity for 
binding towards NADH compared to INH is 
clearly demonstrated. INH can only covalently 
bound to NADH after it has been metabolized 
by katG and the binding of NADH only 
occurs in InhA (Johnsson & Schultz, 1994).  
In the present study, we did not consider 
the involvement of KatG enzyme directly. 
However, presuming that INH must be 
metabolized first by KatG enzyme to form the 
activated INA-NADH that has the inhibitory 
activity against InhA, then hypothetically, the 
binding of this compound to InhA must be 
significantly greater than the parent drug, INH 
(i.e. the predicted free energy of binding must 
be more negative or lower Ki value). In fact, 
the predicted results clearly showed that ∆G 
for INA-NADH and NADH are much more 
negative (nearly 3-fold in the case of INA-
NADH and 2.1-fold for NADH) compared to 
INH, indicating that INA-NADH and NADH 
are highly required for the activity of INH. It 
can be also postulated that should the 
activation of INH does not take place either 
because of mutation or absence of KatG, the 
INH could still have the activity against the 
mycobacterium but at the activity much 
lowered to that if KatG is functional. This 
result is in agreement with many experimental 
studies, where most INH resistant strains due 
to KatG mutation have the MIC of 4.0-5.0 
µg/ml in sensitive strains (Lei et al., 2000; van 
Doorn et al., 2001).  
The lower free energy of binding of INA-
NADH and much more lower Ki value of 
NADH compared to that of INH clearly 
demonstrate that INA-NADH have better 
binding affinity of towards InhA and support 
the experimental observation by Zhang et al. 
(1993), Cynamon et al. (1999), Manca, et al. 
(1999), Chouchane et al. (2000), and Lei et al. 
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 (2000) that INH is a prodrug which needs to 
be activated by katG gene product, the 
catalase-peroxidase, before it acts as an 
important antituberculosis (Sarich et al., 
1998).  
Even though it is clear from the argument 
above that KatG is more responsible to the 
resistance to INH, InhA is undoubtedly has 
been shown to be the main site of action for 
INH. It has a major role in cell wall synthesis 
and the inhibition of which will eventually 
lead to M. tuberculosis cell death. This should 
be the basis for its selection as a drug target 
for the rational design of INH alternatives. 
This enzyme active site consists of a 
hydrophobic pocket formed by aromatic and 
non-polar amino acid residues (Rozwarski et 
al., 1998; Dessen et al., 1995). From the 
binding mode of INADH and the active site of 
InhA, one can suggest that for drug design, at 
least at the virtual level, the proposed new 
structure should not be subjected to the 
metabolism by KatG but be more hydrophobic 
so that it can fit into the hydrophobic pockets 
or it should have a high degree of structural 
similarity to NADH so that it can 
competitively bind to the active site with 
similar affinity to NADH, have some of the 
key pharmacophoric features of NADH or 
even being a small molecule which can bind 
simultaneously with NADH at the binding 
site. 
The differences between the energy from 
docking and MD simulations is not so 
surprising because in MD simulations, the 
water molecules in the binding sites are 
treated explicitly while the solvent description 
in docking is limited to the oversimplified 
atomic solvation parameters (Luzhkov et al., 
2003).  
INH derivatives were the competitive 
inhibitors in InhA where they were found bind 
at the same binding site with INADH. 
Although the INH derivatives bound with both 
WT and MT InhA in different conformation 
but they still at the same InhA active site. 
Since the INADH binding site is the 
combination of most hydrophobic amino acid 
therefore it is expected that the INH 
derivatives, which is consist of aliphatic side 
chain and is hydrophobic, will fit well and 
stable in the hydrophobic binding region with 
INADH (Campbell, 1995; Sewald & Jakubke, 
2002). Intermolecular energy is involved in 
the calculation of free energy in AutoDock 
(Morris et al, 1998), therefore it can be 
explained that as the aliphatic chain in the 
INH derivative getting longer, basically there 
will more van der Waals interaction, 
electrostatic interaction and hydrophobic 
contact with InhA binding site and therefore 
the docked energy is getting lower as the 
aliphatic chain of INH derivative is getting 
longer thus increase the binding affinity with 
InhA.  It is found that the number of hydrogen 
bond, electrostatic interaction, hydrophobic 
contact, π-π interaction and van der Waals 
interaction in INH derivatives were more to 
MT InhA. Therefore it is expected that the 
estimated free energy of INH derivatives 
binding were lower than in WT InhA. This 
trend of improved binding affinity in INH 
derivatives with longer aliphatic chain has 
agreed with Rastogi et al. (1990) and Mellor 
et al. (2003) that the longer the alkyl chain in 
a compound, the better anti-microorganism 
activity the compound will be. The 
hydrophilic serine to hydrophobic alanine 
substitution in MT InhA might explained the 
lower free energy of INH derivatives found in 
MT InhA where the aliphatic chain of INH 
derivatives more comfortable in the 
hydrophobic surrounding (Saint-Joanis et al., 
1999).  
Overall, the INADH still have the 
favourite free energy and Ki value in both WT 
and MT InhA as compare with INH 
derivatives. Therefore, in both WT and MT 
InhA M. tuberculosis INH is still be best 
solution as is will be hydrolyse into its active 
form- INADH. In the case of WT InhA with 
any katG mutation where INH cannot be 
hydrolysed, from the dock results, INH20 will 
be the best solution to treat mutant M. 
tuberculosis as it was having the lowest free 
energy and Ki among the INH derivatives. 
This is agreed with the experimental data 
where from the longer the alkyl side from the 
INH, the lower of the MIC value. While in 
MT InhA with any katG mutation, INH11 and 
INH16 will be the better inhibitor in M. 
tuberculosis INH itself only has a Ki value of 
2.68 x 10-5. However, although INH 
derivative with a long alkyl chain show better 
binding energy and MIC value, but this 
aliphatic chain might be toxic to the human 
body. Mellor et al. (2003) found that 
compounds with eight or fewer carbon atoms 
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 in the alkyl chain were non-toxic in tissue 
culture cells, however, although compounds 
with alkyl chain length above eight carbon 
atoms showed better inhibition activity but 
these compounds also increased the 
cytotoxicity increase with alkyl chain length. 
Hence to reduce the cytotoxicity of the INH 
derivatives, the introduction of an oxygen 
atom might help where according to Tan et al. 
(1994), the oxygen molecule in the side-chain 
will reduce the amphiphilicity of the 
molecule, and also decreases the cellular 
toxicity and improves the therapeutic index of 
the compound. 
Theoretical calculation results compare 
with the experimental MIC value from 
Ibrahim (1996) and Mohamad et al. (2004) 
were found at the same trend. The MIC values 
the getting lower from INH6 to INH18. 
However the MIC values given is at the 
cellular stage where the derivatives might be 
hydrolysed and form isonicotinic acyl anion or 
radical by KatG as the amide group of these 
derivatives is open for KatG attacked and this 
isonicotinic acyl anion or radical will bind 
covalently with NADH to form INADH, 
which is the active inhibitor for InhA. 
Therefore it can be explained that the MIC for 
INH6-8 is at higher value. INH9, INH14, 
INH16 and INH18 were showing very 
favourable MIC might because of the steric 
hindrance from by the long alkyl group to 
protect the amide bond being attack and break 
by KatG (Shoeb et al., 1985; Johnsson & 
Schultz, 1994; Rozwarski et al., 1998), hence 
these INH derivatives showed a good 
alternative of INH. A better way of study 
whether these INH derivatives are better 
solution to replace INH is by conducting an 
enzymatic study (Saint-Joanis et al., 1999) 
where only InhA enzyme will be taken into 
consideration to investigate whether the 
derivatives is actually inhibit the InhA.  
The epidemiologi of tuberculosis has 
altered due to emergence of HIV infection and 
the propagation of drug resistant strains and 
95% of those new cases and deaths were in 
developing countries. In short term, cheap, 
effective and low toxicity chemotherapeutic 
agents are desperately needed, particularly for 
the treatment of emerging drug resistant 
strains (Biava et al., 2004) as the lack of 
priority in the development of novel agents is 
in part due to a poor financial return on 
investment available from drugs primarily 
targeted at a disease which is perceived as a 
“Third World” problem. Therefore, further 
understanding of the mode of action of INH 
derivatives will reveal vital weakness of the 
tubercle bacillus, which will lead to more 
effective diagnostics and may be effectively 
exploited in the production of second 
generation chemotherapeutics. 
 
Conclusions 
Docking results indicated that INH 
activated to INA-NADH has higher binding 
affinity towards InhA. The study 
demonstrated that the activation of INH to 
INA-NADH not only results in the changes in 
the way the ligands bind to the target enzyme 
by making more hydrogen bonds but the 
activated complex formed made better 
hydrophobic contact, more van der Waals and 
electrostatic as well as the aromatic ring 
stacking interactions which strengthen the 
binding affinity of INA-NADH compared to 
the parent compound, INH.  The simulation is 
also able to address the resistance mechanism 
towards INH in InhA mutant strains of M. 
tuberculosis. The S94A substitution probably 
causes INH resistance through weak binding 
of INA-NADH with less hydrogen bond and 
weaker π-π interactions. Since the binding 
affinity of INA-NADH and NADH are much 
greater than INH, it clearly supports that S94A 
mutation is a low level INH resistance as 
reported by Banerjee et al. (1994). We have 
also implicitly argued that the presence of 
KatG is highly necessary so as to convert the 
INH to INA-NADH the ultimate inhibitor of 
InhA. The results also suggest that designing 
new anti-tuberculosis drug that is not 
subjected to KatG enzyme, or improving the 
INH structure similar to INA-NADH structure 
might be a viable approach to overcome INH 
resistant tuberculosis. 
Docking and MD simulations of INADH-
InhA showed similarity in the complex 
conformation. The differences between the 
energy from docking and MD simulations is 
because of the difference in the treatment of 
water molecule. 
With the INH derivative molecule size 
getting bigger, the more interaction were 
made with the InhA binding site, hence 
explained the more favourable free energy in a 
bigger size INH derivatives. However, in the 
sensitive strain of M. tuberculosis (WT InhA), 
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 the INH derivatives have made not much 
effect towards InhA inhibitions as activated 
INH still the best inhibitor for InhA. In MT 
InhA, INADH remains the best inhibitor. 
However, in the absent of activated INH, 
INH11 and INH16 remain a better inhibitor 
compare with un-hydrolyse INH and other 
INH derivatives. Steric hindrance in long 
alkyl chain INH derivatives might help to 
avoid the attack of KatG to break the amide 
bond. Docking simulation has shown to be 
able to predict the binding mode of ligand-
enzyme as results have also shown that the 
theoretical calculation and experimental data 
were correlated with each other. This has also 
suggested molecular modelling simulation is a 
viable approach the new drug design. INH 
derivatives with a longer alkyl chain have 
higher inhibition activity have agrees with 
some researches finding (Rastogi et al., 1990; 
Mellor et al., 2003). Overall these data 
provide further definition of the molecular 
features of new antituberculosis where the 
cytotoxicity of these INH derivatives 
compound with long aliphatic chain can be 
improved by adding oxygen atom(s). This 
study has suggested that the designation of 
new antituberculosis drug or re-design of the 
INH molecule to improve drug binding 
affinity a viable approach and might be faster 
to discover new antituberculosis drug to 
overcome INH resistance in katG or inhA 
gene.  
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